John P. Bilezikian

Credentials: · · · ·

History

Post-acute COVID-19 syndrome
Review · Nature Medicine · 2021 · 3,389 citations
Extrapulmonary manifestations of COVID-19
Review · Nature Medicine · 2020 · 2,208 citations
Guidelines for diagnosis and therapy of MEN type 1 and type 2
Review · The Journal of Clinical Endocrinology & Metabolism · 2001 · 1,355 citations

Role of the Gut Microbiome in the Bone Loss Induced by Hyperparathyroidism in Mice and Humans
National Institute of Diabetes and Digestive and Kidney Diseases · R01
PI · $2.4M · Emory University
2021–2026
Eighteenth Forum on Osteoporosis and Metabolic Bone Diseases for Fellows in Training
National Institute of Arthritis and Musculoskeletal and Skin Diseases · R13
Contact PI · $43.4K · Columbia University Health Sciences
2023–2025
16th Fellows Forum on Osteoporosis and Metabolic Bone Disease
National Institute of Arthritis and Musculoskeletal and Skin Diseases · R13
Contact PI · $27K · Columbia University Health Sciences
2022–2023
15th Fellows Forum on Osteoporosis and Metabolic Bone Diseases
National Institute of Arthritis and Musculoskeletal and Skin Diseases · R13
Contact PI · $15K · Columbia University Health Sciences
2021–2022

Coral Calcium's Effect on Bone Density in Postmenopausal Women With and Without Ibandronate
Principal investigator · Completed · Phase 2
Columbia University
2020–2023
Denosumab in Primary Hyperparathyroidism
Principal investigator · Terminated · Phase 4
Columbia University
2012–2014
ADD-ON Study to Existing Hypoparathyroidism Studies
Principal investigator · Unknown · Phase 3
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
2010–2021
Radius Loading in Primary Hyperparathyroidism
Principal investigator · Completed
Columbia University
2010–2014